聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 21 分钟 55 秒 前

Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin

周一, 08/11/2014 - 16:19
PARIS and VALENCIA, Calif., Aug. 11, 2014 -- (Healthcare Sales & Marketing Network) -- Sanofi (EURONEXT: SAN and NYSE: SNY) and MannKind Corporation (MNKD) announced today that they have entered into a worldwide exclusive licensing agreement for developme...
Biopharmaceuticals, Endocrinology, Drug Delivery, Licensing
Sanofi, MannKind, Afrezza, insulin

Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer

周一, 08/11/2014 - 16:14
CHESTERBROOK, Pa., Aug. 11, 2014 -- (Healthcare Sales & Marketing Network) -- Auxilium Pharmaceuticals, Inc. (AUXL), a fully integrated specialty biopharmaceutical company, announced that Andrew Saik will be appointed Chief Financial Officer, effective Au...
Biopharmaceuticals, Personnel
Auxilium Pharmaceuticals, XIAFLEX

Niklas Prager Appointed New President and CEO of Medivir

周一, 08/11/2014 - 12:59
STOCKHOLM--(Healthcare Sales & Marketing Network)--Medivir AB (MVIR-B.ST) today announces that the company’s Board of Directors has appointed Niklas Prager as new President and CEO of Medivir AB effective 1 September 2014. Niklas Prager will succeed Maris ...
Biopharmaceuticals, Personnel
Medivir AB

EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)

周一, 08/11/2014 - 12:38
TARRYTOWN, N.Y., Aug. 11, 2014 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual imp...
Biopharmaceuticals, Ophthalmology, Regulatory
Regeneron Pharmaceuticals, EYLEA, aflibercept, Diabetic Macular Edema

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong